Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138342502> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2138342502 endingPage "1031" @default.
- W2138342502 startingPage "1023" @default.
- W2138342502 abstract "To compare the safety, tolerability, and efficacy of bimatoprost 0.03% instilled once daily or twice daily with timolol 0.5% twice daily.Multicenter, 3-month, randomized, double-masked, interventional comparison trial.Patients diagnosed with ocular hypertension or glaucoma (n = 596).Patients received bimatoprost 0.03% ophthalmic solution once daily (8 PM, with vehicle control at 8 AM), bimatoprost 0.03% twice daily (8 AM; 8 PM), or timolol 0.5% twice daily (8 AM; 8 PM) in an uneven 2:2:1 randomization. Scheduled visits were at prestudy, baseline (day 0), weeks 2 and 6, and month 3. Intraocular pressure (IOP) was measured at 8 AM (predose), 10 AM, and 4 PM.The primary outcome measure was reduction in IOP in the eye with higher IOP at baseline. Secondary outcome measures included safety variables (adverse events, ophthalmoscopy, biomicroscopy, iris pigmentation, laser-flare meter, visual acuity, visual fields, heart rate, blood pressure, blood chemistry, hematology, and urinalysis).At month 3, the mean reduction in IOP from baseline at 8 AM was 9.16 mmHg (35.2%) with bimatoprost once daily, 7.78 mmHg (30.4%) with bimatoprost twice daily, and 6.74 mmHg (26.2%) with timolol twice daily. At all follow-up visits, mean IOP reductions were significantly greater in the bimatoprost once daily group than in the timolol group at each time point (8 AM, 10 AM, and 4 PM; P < 0.001). Twice-daily dosing of bimatoprost also provided significantly greater mean reductions in IOP than timolol at most time points but was not as effective as once-daily dosing. Bimatoprost was associated with significantly more hyperemia and eyelash growth than timolol, whereas timolol was associated with significantly more burning and stinging sensation in eyes. Overall, bimatoprost was well tolerated with few discontinuations because of adverse events.Bimatoprost 0.03% once daily was safe and statistically superior to timolol 0.5% twice daily in lowering IOP in patients with ocular hypertension or glaucoma. Bimatoprost given once daily consistently provided IOP reductions approximately 2 to 3 mmHg greater than those provided by timolol. Once-daily dosing of bimatoprost, 0.03%, demonstrated greater IOP-lowering effect and better ocular tolerability than twice-daily dosing." @default.
- W2138342502 created "2016-06-24" @default.
- W2138342502 creator A5017887491 @default.
- W2138342502 creator A5026165592 @default.
- W2138342502 creator A5056200231 @default.
- W2138342502 creator A5089416350 @default.
- W2138342502 date "2001-06-01" @default.
- W2138342502 modified "2023-09-23" @default.
- W2138342502 title "Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP" @default.
- W2138342502 cites W1490909919 @default.
- W2138342502 cites W1509798697 @default.
- W2138342502 cites W1711622231 @default.
- W2138342502 cites W1970065450 @default.
- W2138342502 cites W1989529326 @default.
- W2138342502 cites W1996539435 @default.
- W2138342502 cites W2015103799 @default.
- W2138342502 cites W2023397389 @default.
- W2138342502 cites W2055384506 @default.
- W2138342502 cites W2056397917 @default.
- W2138342502 cites W2060586423 @default.
- W2138342502 cites W2063837435 @default.
- W2138342502 cites W2076260416 @default.
- W2138342502 cites W2083838767 @default.
- W2138342502 cites W2105040157 @default.
- W2138342502 cites W4231714144 @default.
- W2138342502 doi "https://doi.org/10.1016/s0161-6420(01)00584-x" @default.
- W2138342502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11382623" @default.
- W2138342502 hasPublicationYear "2001" @default.
- W2138342502 type Work @default.
- W2138342502 sameAs 2138342502 @default.
- W2138342502 citedByCount "141" @default.
- W2138342502 countsByYear W21383425022012 @default.
- W2138342502 countsByYear W21383425022013 @default.
- W2138342502 countsByYear W21383425022014 @default.
- W2138342502 countsByYear W21383425022015 @default.
- W2138342502 countsByYear W21383425022016 @default.
- W2138342502 countsByYear W21383425022017 @default.
- W2138342502 countsByYear W21383425022018 @default.
- W2138342502 countsByYear W21383425022019 @default.
- W2138342502 countsByYear W21383425022020 @default.
- W2138342502 countsByYear W21383425022021 @default.
- W2138342502 countsByYear W21383425022022 @default.
- W2138342502 countsByYear W21383425022023 @default.
- W2138342502 crossrefType "journal-article" @default.
- W2138342502 hasAuthorship W2138342502A5017887491 @default.
- W2138342502 hasAuthorship W2138342502A5026165592 @default.
- W2138342502 hasAuthorship W2138342502A5056200231 @default.
- W2138342502 hasAuthorship W2138342502A5089416350 @default.
- W2138342502 hasConcept C118487528 @default.
- W2138342502 hasConcept C126322002 @default.
- W2138342502 hasConcept C197934379 @default.
- W2138342502 hasConcept C2776521421 @default.
- W2138342502 hasConcept C2777336333 @default.
- W2138342502 hasConcept C2778073030 @default.
- W2138342502 hasConcept C2778190193 @default.
- W2138342502 hasConcept C2778257484 @default.
- W2138342502 hasConcept C2778375690 @default.
- W2138342502 hasConcept C2778527774 @default.
- W2138342502 hasConcept C2781092963 @default.
- W2138342502 hasConcept C42219234 @default.
- W2138342502 hasConcept C71924100 @default.
- W2138342502 hasConceptScore W2138342502C118487528 @default.
- W2138342502 hasConceptScore W2138342502C126322002 @default.
- W2138342502 hasConceptScore W2138342502C197934379 @default.
- W2138342502 hasConceptScore W2138342502C2776521421 @default.
- W2138342502 hasConceptScore W2138342502C2777336333 @default.
- W2138342502 hasConceptScore W2138342502C2778073030 @default.
- W2138342502 hasConceptScore W2138342502C2778190193 @default.
- W2138342502 hasConceptScore W2138342502C2778257484 @default.
- W2138342502 hasConceptScore W2138342502C2778375690 @default.
- W2138342502 hasConceptScore W2138342502C2778527774 @default.
- W2138342502 hasConceptScore W2138342502C2781092963 @default.
- W2138342502 hasConceptScore W2138342502C42219234 @default.
- W2138342502 hasConceptScore W2138342502C71924100 @default.
- W2138342502 hasIssue "6" @default.
- W2138342502 hasLocation W21383425021 @default.
- W2138342502 hasLocation W21383425022 @default.
- W2138342502 hasOpenAccess W2138342502 @default.
- W2138342502 hasPrimaryLocation W21383425021 @default.
- W2138342502 hasRelatedWork W1970476186 @default.
- W2138342502 hasRelatedWork W1976486265 @default.
- W2138342502 hasRelatedWork W1978430571 @default.
- W2138342502 hasRelatedWork W2010755453 @default.
- W2138342502 hasRelatedWork W2128476364 @default.
- W2138342502 hasRelatedWork W2170698422 @default.
- W2138342502 hasRelatedWork W2322571957 @default.
- W2138342502 hasRelatedWork W2612340917 @default.
- W2138342502 hasRelatedWork W3182592653 @default.
- W2138342502 hasRelatedWork W4229042455 @default.
- W2138342502 hasVolume "108" @default.
- W2138342502 isParatext "false" @default.
- W2138342502 isRetracted "false" @default.
- W2138342502 magId "2138342502" @default.
- W2138342502 workType "article" @default.